Upton Welcomes Enactment of Drug Quality and Security Act

November 27, 2013

WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) today applauded the president’s signing of H.R. 3204, the Drug Quality and Security Act, into law. H.R. 3204 was the product of a yearlong investigation and bipartisan negotiation that led to this breakthrough agreement. This law will protect traditional pharmacies and clarify laws related to human drug compounding in response to the nationwide meningitis outbreak – one of the largest public health crises in recent memory. Second, the bill would strengthen the prescription drug supply chain in order to defend American families against counterfeit drugs and protect jobs.

“With the president’s signature today, this bipartisan law will help prevent future crises like last year’s deadly fungal meningitis outbreak while also establishing a unified framework for maintaining safety throughout the drug supply chain. Across the nation, Americans going to their doctor’s office or pharmacy will now have the confidence that their drugs are safe,” said Chairman Upton. “From bipartisan oversight to drafting and approving legislation, we were able to reach a compromise to protect the drug supply and also remove regulatory roadblocks, creating an environment conducive to job creation. I am thankful for the cooperation of my colleagues in both the House and the Senate, on both sides of the aisle, for their efforts in this achievement.”

The Drug Quality and Security Act passed the House of Representatives on September 28 and cleared the Senate on November 18.